At a panel discussion at Emerson's Users Exchange in September, Helen Winkle, Director of FDA's Office of Pharmaceutical Science at the Center for Drug Evaluation and Research, discussed the need for industry, and reviewers, to focus on information that is critical to product quality and safety. For more information, visit www.PharmaManufacturing.com.
Link to this comment:
All Comments (0)